杨贵妃秘史

支持DDR5-8800+频率！七彩虹Z890M ULTRA发售：嘻哈涂鸦风 售1599元_我的网站

一 |     Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

二 |     8月26日消息，七彩虹今日正式发布iGame Z890M ULTRA W V20主板，目前该主板已上架京东平台，官方定价1599元。     据七彩虹官方介绍，iGame Z890M ULTRA W V20在设计逻辑上融入了“嘻哈律动”主题，通过动感的涂鸦图案与纯白接口物料，迎合了目前DIY市场流行的全白装机风格。         在核心性能规格方面，该主板采用了14+1+1+1相DrMOS供电设计，单相电流达60A，配合8层低损耗PCB与聚合物铝电容，足以应对Ultra 200S系列台式机处理器的功耗需求。     内存方面，主板配备四条DDR5 DIMM插槽，支持最高DDR5-8800+(OC)频率，最大容量可达192GB，并全面兼容Intel XMP 3.0内存配置文件。    外观与结构设计上，主板沿用了ULTRA系列的白色散热装甲，并加入了新一代显卡与M.2接口的快拆设计，简化了装机与维护流程。         软件层面，该产品搭载了七彩虹MOORE版图形化BIOS，并支持通过iGame Center同步调节全家桶灯效。    接口布局上，主板共配备了5个M.2接口，其中一个为PCIe 5.0 x4通道，另外4个为PCIe 4.0 x4通道，后置I/O面板提供了1个USB 20Gbps Type-C、1个USB 10Gbps Type-C以及多个USB Type-A接口。     网络连接方面，主板集成了联发科MT7925无线网卡，支持Wi-Fi 7与蓝牙5.4技术，并配备了单5Gbps高速有线网口。         

Current article:http://ntwd.cuozubeishenjingli.cfd/nlnj3mn/cac8r.html

Published on:07:34:24